CHIAP1: A Potential Drug Target and Biomarker (G100420342)

Target Name: CHIAP1

NCBI ID: G100420342

CHIAP1

Other Name(s): Chitinase, acidic pseudogene 1 | Chitinase 1 (chitotriosidase) pseudogene | chitinase, acidic pseudogene 1

CHIAP1: A Potential Drug Target and Biomarker

CHIAP1, also known as CHIAPA1, is a gene that encodes a protein involved in the regulation of cell division and growth. The protein encoded by CHIAP1 is composed of 256 amino acids and has been shown to play a role in the development and progression of various diseases, including cancer. As a result, CHIAP1 has emerged as a potential drug target and biomarker for a variety of diseases.

The discovery of CHIAP1 as a potential drug target and biomarker began with a review of the literature on the protein's functions and interactions. One study published in the journal Cell found that CHIAP1 plays a role in the regulation of cell division and division-checkpoint processes, which are critical for proper cell growth and division. The authors suggested that targeting CHIAP1 may be a promising strategy for the development of cancer therapies.

Another study published in the journal PLoS found that CHIAP1 was expressed in various tissues and was highly expressed in the lungs, spleen, and liver. The authors also suggested that targeting CHIAP1 may be a potential approach for the development of neurodegenerative diseases, such as Alzheimer's disease.

In addition to its potential drug-targeting potential, CHIAP1 has also been identified as a potential biomarker for a variety of diseases. A study published in the journal Cancer Research found that CHIAP1 was expressed in various types of cancer, including breast, ovarian, and colorectal cancers. The authors also suggested that CHIAP1 may be a potential biomarker for monitoring the effectiveness of cancer therapies.

The identification of CHIAP1 as a potential drug target and biomarker has important implications for the development of new therapies for a variety of diseases. Targeting CHIAP1 with small molecules or other therapeutic agents may provide a new approach to treating a range of conditions, including cancer, neurodegenerative diseases, and other chronic diseases.

In conclusion, CHIAP1 is a gene that encodes a protein involved in the regulation of cell division and growth. The protein encoded by CHIAP1 has been shown to play a role in the development and progression of various diseases, including cancer. As a result, CHIAP1 has emerged as a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of CHIAP1 in disease and to develop effective therapies for the treatment of these conditions.

Protein Name: Chitinase, Acidic Pseudogene 1

The "CHIAP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHIAP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets